Dr. Manish Jain

Franciscan Physician Network
Lafayette, IN
Specialties:Nephrology
Accepting New Patients
15 Years of Experience
OverviewInsuranceLocationsClinical Research

Overview

Manish Jain is a Nephrologist in Lafayette, Indiana. Dr. Jain has been practicing medicine for over 15 years. His top areas of expertise are Renovascular Hypertension, Nephrosclerosis, Myeloproliferative Neoplasms (MPN), and Chronic Kidney Disease. Dr. Jain is currently accepting new patients.

His clinical research consists of co-authoring 5 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
2010
Specialties
Nephrology
Licenses
Internal Medicine in IN
Hospital Affiliations
Indiana University Health White Memorial Hospital
Franciscan Health Lafayette
Franciscan Health Rensselaer, Inc
Franciscan Health Crawfordsville
Languages Spoken
English
Hindi
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  CareSource

Locations

FRANCISCAN PHYSICIAN NETWORK
3920 St Francis Way, Suite 220, Lafayette, IN 47905
765-428-5950

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Active_not_recruiting
Publish Date: January 22, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Biological, Drug
Study Drugs: GSK3196165, Tofacitinib, Methotrexate, Folic acid
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies as Pre-Exposure Prophylaxis to Prevent COVID-19 in Immunocompromised Participants
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies as Pre-Exposure Prophylaxis to Prevent COVID-19 in Immunocompromised Participants
Enrollment Status: Terminated
Publish Date: July 24, 2023
Intervention Type: Drug
Study Drug: Casirivimab+Imdevimab
Study Phase: Phase 3
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
Enrollment Status: Completed
Publish Date: July 17, 2023
Intervention Type: Drug, Biological
Study Drugs: GSK3196165, Sarilumab, csDMARDs
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Baricitinib in Patients With COVID-19 Infection
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Baricitinib in Patients With COVID-19 Infection
Enrollment Status: Completed
Publish Date: July 28, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Phase 1, Multi-Center, Open-Label, Safety and Tolerability Study of Intravenous Administration of ST266 in Subjects With Confirmed COVID-19 Infection
A Phase 1, Multi-Center, Open-Label, Safety and Tolerability Study of Intravenous Administration of ST266 in Subjects With Confirmed COVID-19 Infection
Enrollment Status: Completed
Publish Date: June 15, 2022
Intervention Type: Biological
Study Drug: ST266
Study Phase: Phase 1
Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 IgG Antibody Test in Fingerstick Whole Blood
Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 IgG Antibody Test in Fingerstick Whole Blood
Enrollment Status: Completed
Publish Date: June 18, 2021
Intervention Type: Diagnostic test
View 6 Less Clinical Trials

5 Total Publications

Venetoclax-based low intensity therapy in molecular failure of NPM1-mutated AML.
Venetoclax-based low intensity therapy in molecular failure of NPM1-mutated AML.
Journal: Blood advances
Published: June 30, 2023
Similar Doctors
Expertise in
7
conditions
Dr. Sudha Rani
Nephrology
Expertise in
7
conditions
Dr. Sudha Rani
Nephrology

Unity Healthcare LLC

166 Sagamore Pkwy W, Garan Chadha Md, 
West Lafayette, IN 
 (5.7 mi)
765-449-2458
Languages Spoken:
English
See accepted insurances

Sudha Rani is a Nephrologist in West Lafayette, Indiana. Dr. Rani is highly rated in 7 conditions, according to our data. Her top areas of expertise are Renovascular Hypertension, Nephrosclerosis, Acute Kidney Failure, and End-Stage Renal Disease (ESRD).

Expertise in
7
conditions
Dr. Rabih Kalakeche
Nephrology
Expertise in
7
conditions
Dr. Rabih Kalakeche
Nephrology

Arnett Clinic LLC

915 Mezzanine Dr, A, 
Lafayette, IN 
 (0.9 mi)
765-448-8000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Rabih Kalakeche is a Nephrologist in Lafayette, Indiana. Dr. Kalakeche is highly rated in 7 conditions, according to our data. His top areas of expertise are Chronic Kidney Disease, Acute Kidney Failure, End-Stage Renal Disease (ESRD), and Nephrosclerosis.

Expertise in
9
conditions
Dr. Akram Al
Nephrology
Expertise in
9
conditions
Dr. Akram Al
Nephrology

Arnett Clinic LLC

2600 Greenbush St, 
Lafayette, IN 
 (3.2 mi)
765-448-8000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Akram Al is a Nephrologist in Lafayette, Indiana. Dr. Al is highly rated in 9 conditions, according to our data. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Nephrosclerosis, and Renovascular Hypertension.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile